There are two treatment options: intrauterine placement of Mannorrhea and endometrial removal. Mannorrhea is an intrauterine release system that releases highly effective progesterone. When placed in the uterine cavity, the endometrium shrinks and menstrual bleeding becomes less frequent or even interrupted. It has no effect on the ovaries. It can effectively prevent and treat endometrial hyperplasia and is even used in young patients with endometrial cancer who wish to preserve their uterus. It is used during the perimenopausal period to help smooth out the menopause. Effective for 5-7 years, when you have confirmed menopause, estrogen alone can be used to improve menopausal symptoms without the addition of progestin. Endometrial removal is a convenient and effective way to treat menopausal menstrual bleeding. It is a minimally invasive procedure in which the endometrium is removed hysteroscopically. After the procedure, there is usually no recurrence of menstruation and there is no effect on ovarian function. The disadvantage is that it does not prevent endometrial cancer (early stage endometrial cancer will have dripping bleeding and this symptom disappears after removal of the endometrium, which is not conducive to early detection). It is often used for patients who are not convenient to follow up. Low estrogen level after menopause leads to accelerated aging of many tissues and organs throughout the body, and a series of symptoms may occur. Recent menopausal symptoms such as hot flashes, sweating and palpitations may later lead to cardiovascular disease, osteoporosis, senile vaginitis and urethritis, reducing the quality of life. Therefore, regular use of estrogen preparations after menopause is recommended to delay aging and improve the quality of life. HRT methods, emphasizing individualization, must be used under medical supervision.